Open AccessPractical consensus recommendations on Her2 +ve breast cancer with solitary brain mets
Author(s) -
Nitesh Rohatgi,
Anusheel Munshi,
Prachi Bajpai,
Manish Kumar Singh,
Sunil K. Sahai,
Mansoor Ahmad,
Karan P. Singh,
Harpreet Singh,
Purvish M. Parikh,
Sandeep Aggarwal
Publication year - 2018
Publication title -
south asian journal of cancer
Language(s) - English
Resource type - Journals
eISSN - 2278-4306
pISSN - 2278-330X
DOI - 10.4103/sajc.sajc_116_18
Subject(s) - medicine , radiosurgery , breast cancer , radiation oncologist , oncology , radiation therapy , quality of life (healthcare) , expert opinion , incidence (geometry) , cancer , brain metastasis , medical physics , intensive care medicine , metastasis , physics , nursing , optics
Breast cancer is a common cause of brain metastases, with metastases occurring in at least 10–16% of patients. Longer survival of patients with metastatic breast cancer and the use of better imaging techniques are associated with an increased incidence of brain metastases. Current therapies include surgery, whole-brain radiation therapy, stereotactic radiosurgery, chemotherapy and targeted therapies. However, the timing and appropriate use of these therapies is controversial and careful patient selection by using available prognostic tools is extremely important. Expert oncologist discussed on the mode of treatment to extend the OS and improve the quality of life ofHER2-positivebreast cancer patients with Solitary brain metastases. This expert group used data from published literature, practical experience and opinion of a large group of academic oncologists to arrive at this practical consensus recommendations for the benefit of community oncologists.